Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Thiourea, (6-methyl-2-benzothiazolyl)- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

52112-82-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 52112-82-0 Structure
  • Basic information

    1. Product Name: Thiourea, (6-methyl-2-benzothiazolyl)- (9CI)
    2. Synonyms: Thiourea, (6-methyl-2-benzothiazolyl)- (9CI)
    3. CAS NO:52112-82-0
    4. Molecular Formula: C9H9N3S2
    5. Molecular Weight: 223.31786
    6. EINECS: N/A
    7. Product Categories: BENZOTHIAZOLE
    8. Mol File: 52112-82-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Thiourea, (6-methyl-2-benzothiazolyl)- (9CI)(CAS DataBase Reference)
    10. NIST Chemistry Reference: Thiourea, (6-methyl-2-benzothiazolyl)- (9CI)(52112-82-0)
    11. EPA Substance Registry System: Thiourea, (6-methyl-2-benzothiazolyl)- (9CI)(52112-82-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 52112-82-0(Hazardous Substances Data)

52112-82-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 52112-82-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,1,1 and 2 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 52112-82:
(7*5)+(6*2)+(5*1)+(4*1)+(3*2)+(2*8)+(1*2)=80
80 % 10 = 0
So 52112-82-0 is a valid CAS Registry Number.

52112-82-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (6-methyl-1,3-benzothiazol-2-yl)thiourea

1.2 Other means of identification

Product number -
Other names THIOUREA,(6-METHYL-2-BENZOTHIAZOLYL)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:52112-82-0 SDS

52112-82-0Relevant articles and documents

Benzothiazole thiourea derivatives as anticancer agents: Design, synthesis, and biological screening

Eshkil, Fatemeh,Eshghi, Hossein,Saljooghi, Amir. Sh.,Bakavoli, Mehdi,Rahimizadeh, Mohammad

, p. 576 - 582 (2017/09/27)

In a systematic effort to identify a potent anticancer agent, we synthesized benzothiazole thiourea derivatives and examined their cytotoxic activity against five different human and animal cancer cell lines. Benzothiazolylthiocarbamides have been prepared in excellent yields by reaction of substituted 2-amino benzothiazoles with carbon disulfide and dimethyl sulfate followed by their ammonolysis. Cytotoxicity of the four compounds were screened for antitumor activity against human breast cancer cells (MCF-7), human cervix epithelial carcinoma (HeLa), human colon cancer cell line (HT-29), human leukemia cell line (K-562), and mouse neuroblastoma cell line (Neuro-2a) using cisplatin as a reference by MTT assay. Our results presented herein provide experimental evidence that benzothiazolylthiocarbamides induce apoptosis in cancer cell lines. According to flow cytometry results, treatment of HT-29 cells with 1-(6-ethoxy-1,3-benzothiazol- 2-yl)thiourea produced a large population of apoptotic cell (79.45%), which was 1.2-fold higher than that produced by cisplatin (65.28%) at the same concentration.

SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF CANCERS, INCLUDING HEPATOCELLULAR CARCINOMA, AND AS INHIBITORS OF HEPATITIS VIRUS REPLICATION

-

Paragraph 0135; 0136; 0137, (2013/04/24)

Pharmaceutical compositions of the invention are presented which comprise substiuted aminothiazoles derivatives. The substiuted aminothiazoles derivatives have a disease-modifying action in the treatment of diseases associated with unregulated cell growth. Such diseases include cancers such as hepatocellular carcinoma, and viral infections from a hepatitis virus.

Synthesis of 5-Substituted-benzothiazolylimino-3-arylimino-1,2,4-dithiazolidines

Singh, A. P.,Bhattacharya, A.,Verma, V. K.

, p. 223 - 225 (2007/10/02)

A simple and convenient synthesis of 5--imino-3-arylimino-1,2,4-dithiazolodines (7a-d) has been achieved by the oxidation and cyclisation of the corresponding 1--5-aryl-2-S-allyliso-2,4-dithiobiurets (6a-d), which in turn were prepared by the condensation of 1--2-S-allylisothiocarbamide (5) with appropriate aryl isothiocyanate.The compounds have been characterised by their synthesis through alternative routes, elemental analyses, and also by ir and pmr spectra.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 52112-82-0